ALLMedicine™ Type 2 Diabetes Center

Jan 20th, 2022 - The Japanese diabetes treatment guidelines do not specify the first choice of hypoglycemic agents unlike those of Western countries. Moreover, current situation in diabetes treatment is that the choice of hypoglycemic agents is determined by each ...

Jan 20th, 2022 - Diabetic neuropathy leads to postural instability. This study compared longitudinal changes in neuropathy outcomes relative to long-term glycemic control in patients aged < 60 years with uncontrolled type 2 diabetes with and without a short one-le...

Jan 20th, 2022 - The majority of international guidelines for cardiovascular disease (CVD) prevention recommend moderate intake of low fat or fat-free products, and limiting full fat dairy food because of its high saturated fatty acid content. Recent equivocal obs...

Jan 20th, 2022 - The mechanism underlying postprandial glucagon-like peptide-1 (GLP-1) changes after metabolic surgery remains mostly unclarified. This investigation aimed to address whether the vagus nerve-spleen anti-inflammatory axis is involved in the rise in ...

Jan 20th, 2022 - To present a comprehensive review of the association between measures of body weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes. Systematic review and dose-response meta-analysis of cohort studies. Pub...

Aug 25th, 2021 - An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in older adults. Estimates of the risk of progression from prediabetes to diabetes...

Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...

Jun 2nd, 2021 - Bone fragility is increasingly recognized as a relevant complication of type 2 diabetes (T2D) and diabetic patients with fragility fractures have higher mortality rates than non diabetic individuals or diabetic patients without fractures. However,...

Oct 9th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Oct 2nd, 2020 - Regular exercise is considered a cornerstone in the management of type 2 diabetes mellitus (T2DM). It improves glucose control and cardiovascular risk factors, contributes to weight loss, and also improves general well-being, likely playing a role...

Jan 14th, 2022 - A.1 Significance A.1.1 Physical Activity. The CDC suggests that 150-300 minutes of moderate-intensity physical activity (PA) is important to staving off non-communicable diseases (NCD) such as cancer, type 2 diabetes, and comorbidity health outcom...

Jan 14th, 2022 - Sodium-glucose linked transporters (SGLT-2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors are relatively novel glucose-lowering drugs for the treatment of T2DM. These agents seem to exert pleiotropic actions 'beyond glucose control'. SG...

Jan 13th, 2022 - This study is looking at semaglutide in combination with a potential new medicine (NNC0480-0389) in people with type 2 diabetes. The study is being conducted to see how well semaglutide, in combination with different doses of NNC0480-0389, work to...

Jan 13th, 2022 - This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this study are tablets which lower blood sugar in people with type 2 diabetes. The purpose of the stud...

Jan 12th, 2022 - Insulin resistance and a defect in early insulin secretion are risk factors for the development of type 2 diabetes mellitus. A recent longitudinal analysis which tracked the development of diabetes demonstrated that both insulin action and early i...

Jan 20th, 2022 - Called a "game changer" weight loss drug by some experts, semaglutide is the first such medication approved by the US Food and Drug Administration since 2014. Semaglutide, specifically the brand Wegovy, is indicated for use in adults with obesity ...

Jan 17th, 2022 - The study covered in this summary is a preprint and has not yet been peer reviewed. Key Takeaways The results document a strong, inverse relationship between cardiorespiratory fitness and new-onset type 2 diabetes in a study of more than 8700 peop...

Jan 17th, 2022 - It has long been recognised that those people who are overweight/obese attend hospital more frequently than those who maintain a healthy weight. Now researchers from Bristol Medical School’s Population Health Science Institute have suggested that ...

Jan 14th, 2022 - (Reuters Health) - White and more affluent patients with type 2 diabetes are significantly more likely to receive glucagon-like peptide-1 (GLP-1) receptor agonist therapy than individuals who are Black, Asian, Hispanic or low-income, a U.S. study ...

Jan 13th, 2022 - NEW YORK (Reuters Health) - A new study shows dementia risk follows a U-shape curve after a diagnosis of type 2 diabetes, dropping for nearly five years and then rising again with longer disease duration. "We identified a non-linear association of...